AKT3 and neoplasm: This suggested that the sensitivity of CDH1-null cells to the pan AKT inhibitors may be explained more by the inhibition of AKT3 rather than AKT1 and AKT2, and therefore that over-expression of AKT3 represents a vulnerability in tumours deficient in E-cadherin.